Mentalyc

The documentation model is the entire product and it is purpose-built rather than a general scribe pointed at therapy. The company positions itself explicitly against general-purpose AI medical scribes serving all specialties by focusing wholly on behavioral health documentation, and the output formats reflect that: SOAP, DAP, BIRP, PIRP, GIRP, PIE and SIRP are therapy-specific structures a generic scribe does not produce. Adjacent features including CPT code computation and Alliance Genie relationship tracking are also model-driven. No services layer underneath.

Draft-and-review by design, and third party assessment is explicit that the product suits therapists who are comfortable reviewing and editing notes for clinical and insurance accuracy, which is an honest framing of where the work remains. The multi-input design reinforces clinician control, since notes can be produced from a typed summary or dictation rather than requiring session capture.

Graded B rather than A because no edit-burden or suggestion-acceptance figure is published, the same gap as Blueprint and the reason Eleos Health scores higher on this axis for publishing an approximate 80 percent acceptance rate.

Little technical disclosure. The company states the AI is trained specifically on mental health content and that the system learns and adapts to individual clinicians' documentation styles, but no base model, training data provenance, or accuracy methodology was located. The claim of saving up to 90 percent of documentation time is quoted widely across software directories with no stated measurement basis. Same standard applied to Blueprint in this category.

The boundary is answered as clearly as anywhere in this index and no party is named. Two unqualified commitments cover what this axis asks about content: the vendor states it does not train on clinician or client data, and it does not retain session recordings.

Neither carries the third party, shared model or permission qualifiers that weaken the same claim elsewhere in this index, and an independent third party review corroborates rather than leaving the position resting on vendor assertion alone. Not retaining recordings is structurally stronger than a policy governing retained recordings, because it removes the artefact rather than managing it, and for psychotherapy audio that is the single most consequential design choice available.

On enumeration there is nothing: no model or model family, no foundation model provider, no hosting arrangement and no sub processor list was located. So a buyer knows content does not accumulate and does not train anything, and cannot name a single party that processes it while the note is being produced. Given how specific this vendor is willing to be on the harder question, the list is probably obtainable, and this is a refresh candidate. Ask for the sub processor list and the hosting arrangement.

No peer reviewed study, controlled evaluation or published accuracy assessment was located. Evidence consists of user reviews across software directories and vendor-stated time savings. Note that user feedback is genuinely mixed on substance rather than uniformly positive: at least one Capterra reviewer disputes both the recording capability and the compliance posture, which conflicts with the company's own documentation and with independent reviews confirming SOC 2 Type II.

Buyers should verify current capabilities directly rather than relying on either the vendor or dated reviews. Same C applied to Blueprint for the same reason: adoption and testimonial are not clinical evidence.

The strongest position of any indexed behavioral health vendor and the reason this record earns its place despite a crowded category. The company states clearly that it does NOT train on clinician or client data and does NOT retain session recordings.

Those are the two specific commitments that matter most for a product processing psychotherapy audio, and they are precisely what is missing from Blueprint, Eleos Health and Lyssn, all indexed, where no published training-data or retention position was located. Data minimisation by not retaining recordings is structurally stronger than a policy governing retained data. Independent third party review corroborates rather than relying on vendor claim alone.

HIPAA compliant and additionally PHIPA certified for Canadian practitioners, which is a jurisdictional compliance step almost no vendor in this index takes and which matters because Canadian health privacy law is provincially governed and not satisfied by HIPAA alignment. Independent review characterises the combined HIPAA, PHIPA and SOC 2 Type II position as strong compliance coverage spanning US, Canadian and enterprise security requirements.

SOC 2 TYPE II specifically, not an unqualified SOC 2 claim, which is the distinction that separates a completed audit of controls operating over time from a point-in-time assessment. This is the clearest security attestation in the behavioral health category, where Blueprint, Eleos Health and Lyssn all had no located third party attestation, and it is unusual for a product priced for solo practitioners. Compare Axuall, flagged in this index for stating SOC 2 standards compliance without a completed Type II report; Mentalyc is the opposite case.

Converted from Not Rated. The prior scoping was correct and had no grade attached.

No device pathway applies. Documentation drafting falls outside software as a medical device, and the product neither diagnoses nor directs treatment. Consistent with how this index treats the other behavioural health documentation vendors it holds.

What governs instead is payer documentation standards and audit readiness, which the company targets directly, alongside state licensure and scope of practice rules bearing on what a clinician may delegate to an automated draft.

The unaddressed regime is 42 CFR Part 2, and it is the standing ask for this whole category. Substance use disorder records carry stricter confidentiality than the general health privacy rule, requiring specific patient consent for disclosures the rule would otherwise permit for payment and operations, and restricting redisclosure downstream. The modernised framework reached its enforcement date in February 2026, and the technical requirement it creates is concrete: automated systems must segment those records out of processing unless consent is on file.

The distribution model makes publishing a position more important rather than less. This is sold largely to individual therapists and small practices, where there is no procurement function to raise the question and no compliance officer to answer it, and where substance use treatment is common.

Ask for the written Part 2 position, and whether note handling distinguishes records carrying it.

No governance framework, subgroup analysis or bias evaluation located. The exposure is the same as across this category: speech recognition applied to psychotherapy sessions has documented performance variation across accent, dialect and atypical speech, including speech affected by symptoms or medication.

The strong privacy posture does not address performance equity, which is a distinct question, and the not-training-on-client-data commitment arguably makes model improvement across diverse speech patterns harder rather than easier.

This record is worth reading as a demonstration that the two axes measure different things, because the same vendor holds the strongest data stewardship position of any behavioural health company in this index and has nothing at all on this one. Not training on client data and not retaining session recordings are commitments about what happens to content.

They say nothing about whether the note is right, and a therapist relying on a generated progress note is exposed to a different failure entirely. Two passes located no accuracy or error figure, no published limitations, no evaluation methodology, and no warranty, indemnity or remediation commitment. The stakes in this segment are not the same as in general documentation.

A psychotherapy progress note supports a clinical formulation, is submitted for reimbursement, and can be subpoenaed in custody, criminal and civil proceedings, so an inaccurate note is read years later by parties the client never anticipated.

Risk content is the sharper case: a generated note that omits or misstates disclosed suicidal ideation, abuse or substance use is an error with immediate clinical and legal consequences, and nothing published describes how the system handles that content, whether it flags uncertainty on it, or what the vendor commits to when it is wrong. Ask for accuracy on risk content specifically, and for what the vendor stands behind when a note is inaccurate.

The weakest axis relative to category peers. Independent comparison positions Mentalyc as a documentation tool typically used ALONGSIDE a separate EHR rather than integrating deeply into one or replacing it, in contrast to Upheal which bundles EHR functionality and Blueprint which offers both a browser extension for existing EHRs and its own AI-native EHR. Multi-input flexibility partly compensates by fitting varied workflows, but no named EHR integrations were located.

Flexible input model is the strength: notes can be generated from live recording, uploaded audio, dictation, transcripts or typed summaries, so the product works for clinicians who decline to record sessions, which is a meaningful population in psychotherapy. PHIPA certification implies attention to Canadian data handling requirements. Graded B rather than A because no explicit hosting architecture or data residency terms were located, and because not retaining recordings limits some longitudinal capability.

Fully published tiered pricing with no sales gate, spanning solo to group practice: a Mini plan around $19.99 per month for 40 notes, mid tiers around $49.99 to $69.99 for roughly 100 to 160 notes, a higher volume tier around $119.99, and a group practice plan at roughly $49.99 to $59.99 per seat with unlimited notes, team management and admin visibility, with a free trial and an annual discount reported.

A prospective buyer can determine total cost at their own caseload before contacting anyone. Note that published rates vary somewhat across third party reviews and review dates, so figures should be confirmed on the vendor pricing page, but the model itself is transparent.

Deliberately deep within one vertical rather than broad. Covers therapists, counselors, social workers, psychologists and psychiatric mental health nurse practitioners, with note formats spanning the full range of behavioral health documentation conventions and reported support for 100 or more custom templates. Group practice tiering with admin oversight extends it beyond solo use.

Graded B rather than A because it does not reach the substance use disorder treatment, case management, field-based outreach, home health or hospice settings that Eleos Health covers, and it is a documentation product rather than a care platform.